A detailed history of Beacon Pointe Advisors, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 16,043 shares of BAX stock, worth $527,012. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,043
Previous 16,035 0.05%
Holding current value
$527,012
Previous $619,000 10.66%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$37.88 - $43.77 $303 - $350
8 Added 0.05%
16,043 $685,000
Q4 2023

Feb 08, 2024

SELL
$31.71 - $38.95 $53,938 - $66,253
-1,701 Reduced 9.59%
16,035 $619,000
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $79,678 - $105,234
-2,135 Reduced 10.74%
17,736 $669,000
Q2 2023

Aug 11, 2023

BUY
$39.98 - $47.68 $24,067 - $28,703
602 Added 3.12%
19,871 $905,000
Q1 2023

May 12, 2023

SELL
$37.58 - $52.57 $17,286 - $24,182
-460 Reduced 2.33%
19,269 $781,000
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $10,089 - $11,715
203 Added 1.04%
19,729 $1.01 Million
Q3 2022

Nov 09, 2022

BUY
$53.86 - $66.8 $12,441 - $15,430
231 Added 1.2%
19,526 $1.05 Million
Q2 2022

Aug 11, 2022

SELL
$63.83 - $80.0 $82,596 - $103,520
-1,294 Reduced 6.28%
19,295 $1.24 Million
Q1 2022

May 17, 2022

BUY
$76.85 - $89.45 $568,459 - $661,661
7,397 Added 56.07%
20,589 $1.6 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $69,275 - $80,999
-929 Reduced 6.58%
13,192 $1.13 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $567,291 - $642,960
7,690 Added 119.58%
14,121 $1.14 Million
Q2 2021

Aug 17, 2021

BUY
$80.5 - $88.01 $517,695 - $565,992
6,431 New
6,431 $518,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.